Skip to content
Loading your account…

SYK STRYKER CORP

NYSEHealth careSurgical & Medical Instruments & ApparatusPortage, MIFY ends December 31

New 8-K: Filed an 8-K current report in the last 7 days.Profitable 5/5: Fiscal years with net income above zero, out of the last five reported.FY2025 10-K filed Feb 11, 2026

FY2025 at a glance

Fundamentals from SEC filings, not quotes
Revenue
$25.1BYoYup 11.16%ended Dec 31, 2025
Net income
$3.25B12.9% margin
Diluted EPS
$8.40YoYup 8.25%
Free cash flow
$4.28B17.1% margin
Cash
$4.01BNet debt $10.8B
Total debt
$14.9BD/E 0.66×
About STRYKER CORP

Overview

STRYKER CORP (SYK) is listed on NYSE; the SEC classifies it under "Surgical & Medical Instruments & Apparatus".

For fiscal 2025 (ended Dec 31, 2025) it reported revenue of $25.12B, up 11.2% from fiscal 2024.

Net income was $3.25B, a net margin of 12.9%.

At fiscal year end it had total assets of $47.84B and stockholders' equity of $22.42B (46.9% of assets).

Fiscal years shown
FY2016–FY2025 (10 years)
Latest 10-K
Feb 11, 2026
Latest filing
10-QOct 30, 2026
FY2016–FY2025 · annual 10-K

Charts

Revenue and net income

Revenue and net income, fiscal years FY2016 to FY2025.
PeriodRevenueNet incomeNet margin
FY2016$11.3B$1.65B14.5%
FY2017$12.4B$1.02B8.2%
FY2018$13.6B$3.55B26.1%
FY2019$14.9B$2.08B14.0%
FY2020$14.4B$1.6B11.1%
FY2021$17.1B$1.99B11.7%
FY2022$18.4B$2.36B12.8%
FY2023$20.5B$3.17B15.4%
FY2024$22.6B$2.99B13.2%
FY2025$25.1B$3.25B12.9%

Gross, operating and net margin

Gross, operating and net margin, fiscal years FY2016 to FY2025.
PeriodGross marginOperating marginNet margin
FY201666.2%19.1%14.5%
FY201765.7%18.4%8.2%
FY201865.7%18.7%26.1%
FY201965.1%18.2%14.0%
FY202063.1%15.5%11.1%
FY202164.1%15.1%11.7%
FY202262.8%15.4%12.8%
FY202363.7%19.0%15.4%
FY202463.9%16.3%13.2%
FY202564.0%19.5%12.9%

Diluted EPS

Diluted EPS, fiscal years FY2016 to FY2025.
PeriodEPS (diluted)
FY2016$4.35
FY2017$2.68
FY2018$9.34
FY2019$5.48
FY2020$4.20
FY2021$5.21
FY2022$6.17
FY2023$8.25
FY2024$7.76
FY2025$8.40

Free cash flow vs net income

Free cash flow vs net income, fiscal years FY2016 to FY2025.
PeriodFree cash flowNet income
FY2016$1.32B$1.65B
FY2017$961M$1.02B
FY2018$2.04B$3.55B
FY2019$1.54B$2.08B
FY2020$2.79B$1.6B
FY2021$2.74B$1.99B
FY2022$2.04B$2.36B
FY2023$3.14B$3.17B
FY2024$3.49B$2.99B
FY2025$4.28B$3.25B

Diluted shares

Diluted shares, fiscal years FY2016 to FY2025.
PeriodDiluted shares (weighted)
FY2016379M
FY2017380M
FY2018380M
FY2019380M
FY2020380M
FY2021382M
FY2022382M
FY2023384M
FY2024386M
FY2025387M

Cash vs total debt

Cash vs total debt, fiscal years FY2016 to FY2025.
PeriodCash & equivalentsTotal debt
FY2016$3.32B$6.89B
FY2017$2.54B$6.59B
FY2018$3.62B$8.49B
FY2019$4.34B$10.2B
FY2020$2.94B$13.2B
FY2021$2.94B$12.5B
FY2022$1.84B$11.9B
FY2023$2.97B$10.9B
FY2024$3.65B$12.2B
FY2025$4.01B$14.9B

Each bar is one fiscal year as reported in its 10-K; bars below the zero line are negative and gaps are years not reported. Per-share figures are as reported, not adjusted for stock splits; comparisons across a likely split are left blank.

FY2025 · 5-year trend

Ratios

Profitability

Gross margin
64.0%
Operating margin
19.5%
Net margin
12.9%
FCF margin
17.1%
Return on equity
15.1%
Return on assets
7.1%

Growth

Growth. Compound annual growth: (end ÷ start)^(1 ÷ years) − 1, both ends positive.
Metric1y3y CAGR5y CAGR9y CAGR
Revenueup 11.16%up 10.83%up 11.84%—
EPS (diluted)up 8.25%up 10.83%up 14.87%up 7.59%
Free cash flowup 22.83%up 28.13%up 8.95%up 13.95%
Change in share count
+0.23%

Financial strength

Current ratio
1.89×
Debt / equity
0.66×
Liabilities / assets
53.1%
Net debt
$10.8B
Interest coverage
8.05×
Equity / assets
46.9%

Shareholder returns

Dividends paid
$1.28B
Buybacks
—
Payout ratio
39.6%
Stock comp. / revenue
1.0%
Piotroski F-Score · Altman Z''-Score

Quality screens

Piotroski F-Score

6 of 9 checks passed

FY2025 vs FY2024

  • PassPositive return on assets7.6%
  • PassPositive operating cash flow$5.04B
  • PassReturn on assets improved7.6% vs 7.5%
  • PassOperating cash flow above net income11.7% vs 7.6%
  • FailLong-term debt / assets fell31.1% vs 28.4%
  • FailCurrent ratio improved1.89× vs 1.95×
  • FailNo increase in share count387M vs 386M
  • PassGross margin improved64.0% vs 63.9%
  • PassAsset turnover improved0.58× vs 0.57×

Altman Z''-Score

Safe zone (above 2.60)

FY2025

Altman Z''-Score: Components
ComponentsRatioWeightPoints
Working capital / assets0.145×6.560.95
Retained earnings / assets0.428×3.261.39
Operating income / assets0.102×6.720.69
Equity / liabilities0.882×1.050.93
Z''3.96

Screening heuristic, not a recommendation. Per-share figures are as reported, not adjusted for stock splits; comparisons across a likely split are left blank.

Last 10 fiscal years · newest first

Financial statements

USD millions, except per-share figures (USD). Share counts in millions.

Income statement

Income statement. USD millions, except per-share figures (USD). Share counts in millions.
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023FY2022Dec 31, 2022FY2021Dec 31, 2021FY2020Dec 31, 2020FY2019Dec 31, 2019FY2018Dec 31, 2018FY2017Dec 31, 2017FY2016Dec 31, 2016
Revenue25,11622,59520,49818,44917,10814,35114,88413,60112,44411,325
YoY (Revenue)+11.16%+10.23%+11.11%+7.84%+19.21%-3.58%+9.43%—+9.88%—
Gross profit16,06514,44013,05811,57810,9689,0579,6968,9388,1737,495
Research & development1,6231,4661,3881,4541,235984971862787715
Selling, general & admin.8,6517,6857,1296,4556,4275,3615,3565,0994,5524,137
Operating income4,8893,6893,8882,8412,5842,2232,7132,5372,2902,166
Interest expense607396356337337315287264247228
Pretax income4,5143,4923,6732,6832,2811,9542,5622,3562,0631,921
Income tax1,268499508325287355479-1,1971,043274
Net income3,2462,9933,1652,3581,9941,5992,0833,5531,0201,647
YoY (Net income)+8.45%-5.43%+34.22%+18.25%+24.70%-23.24%-41.37%+248.33%-38.07%—
EPS (basic)8.497.868.346.235.294.265.579.502.734.40
EPS (diluted)8.407.768.256.175.214.205.489.342.684.35
YoY (EPS (diluted))+8.25%-5.94%+33.71%+18.43%+24.05%-23.36%-41.33%+248.51%-38.39%—
Diluted shares (weighted)387386384382382380380380380379

Balance sheet

Balance sheet. USD millions, except per-share figures (USD). Share counts in millions.
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023FY2022Dec 31, 2022FY2021Dec 31, 2021FY2020Dec 31, 2020FY2019Dec 31, 2019FY2018Dec 31, 2018FY2017Dec 31, 2017FY2016Dec 31, 2016
Cash & equivalents4,0113,6522,9711,8442,9442,9434,3373,6162,5423,316
Receivables4,0393,9873,7653,5653,0222,7012,8932,3322,1981,967
Inventory5,3104,7744,8433,9953,3143,4943,2822,9552,4652,030
Current assets14,75514,84712,51810,27510,0179,70711,3609,7337,9937,861
Goodwill19,29115,85515,24314,88012,91812,7789,0698,5637,1686,356
Intangible assets5,6814,3954,5934,8854,8405,5544,2274,1633,4773,508
Total assets47,84442,97139,91236,88434,63134,33030,16727,22922,19720,435
Current liabilities7,7947,6167,9216,3034,5495,0414,4004,8073,4853,148
Short-term debt000000000200
Long-term debt14,85912,18810,90111,85712,47213,23010,2318,4866,5906,686
Total liabilities25,42422,33721,31920,26819,75421,24617,36015,49912,21710,885
Retained earnings20,47218,52816,77114,76513,48012,46211,74810,7658,9868,842
Stockholders' equity22,42020,63418,59316,61614,87713,08412,80711,7309,9669,550
Shares outstanding383382380379378376375373374375

Cash flow

Cash flow. USD millions, except per-share figures (USD). Share counts in millions.
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023FY2022Dec 31, 2022FY2021Dec 31, 2021FY2020Dec 31, 2020FY2019Dec 31, 2019FY2018Dec 31, 2018FY2017Dec 31, 2017FY2016Dec 31, 2016
Operating cash flow5,0444,2423,7112,6243,2633,2772,1912,6101,5591,812
Capital expenditures761755575588525487649572598490
Free cash flow4,2833,4873,1362,0362,7382,7901,5422,0389611,322
YoY (Free cash flow)+22.83%+11.19%+54.03%-25.64%-1.86%+80.93%-24.34%+112.07%-27.31%—
Depreciation & amortization1,5701,4261,3411,2781,2721,0761,044966859752
Stock-based compensation24322920516817114212711911397
Share repurchases————0030730023013
Dividends paid1,2841,2191,1391,051950863778703636568
Dividends per share—————————1.57
Key financials (annual, 10-K)

Values as reported in each fiscal year's Form 10-K (XBRL data on SEC EDGAR); growth and ratios are computed from those values. Revenue is the total revenue figure the company tagged (omitted when the only figure tagged is evidently partial, e.g. below net income); growth is only shown between consecutive ~12-month fiscal years reported with the same revenue measure. Per-share figures and share counts are as reported and not adjusted for later stock splits. — = not reported.

FY2025 · per diluted weighted share

Per share and valuation context

EPS (diluted)
$8.40
Revenue per share
$64.98
FCF per share
$11.08
Book value per share
$58.01
Tangible book per share
-$6.60
Cash per share
$10.38
Public floatas of Jun 30, 2025
$144B

Price ratios need a live quote. This page shows no stock prices. Per-share figures are as reported, not adjusted for stock splits; comparisons across a likely split are left blank.

Price ratio calculator

Type a share price to compute ratios from the latest 10-K figures. Nothing is stored or sent. (FY2025)

Market capPrice × diluted weighted shares
—
P/EPrice ÷ diluted EPS
—
P/BPrice ÷ book value per share
—
P/SPrice ÷ revenue per share
—
P/FCFPrice ÷ FCF per share
—
Dividend yieldDividends per share ÷ price
—
SEC EDGAR

Filing timeline

  1. 10-QNew
    Quarterly report· Sep 30, 2026(SEC EDGAR)
  2. 8-KNew
    Current report· Oct 29, 2026(SEC EDGAR)
    • 2.02Results of operations
    • 9.01Financial statements and exhibits
  3. 8-K
    Current report· Oct 6, 2026(SEC EDGAR)
    • 5.02Officer or director changes
    • 7.01Regulation FD disclosure
    • 9.01Financial statements and exhibits
  4. 10-Q
    Quarterly report· Jun 30, 2026(SEC EDGAR)
  5. 8-K
    Current report· Jul 30, 2026(SEC EDGAR)
    • 2.02Results of operations
    • 9.01Financial statements and exhibits
  6. 8-K
    Current report· Jun 26, 2026(SEC EDGAR)
    • 8.01Other events
    • 9.01Financial statements and exhibits
  7. 8-K
    Current report· May 15, 2026(SEC EDGAR)
    • 5.02Officer or director changes
    • 9.01Financial statements and exhibits
  8. 10-Q
    Quarterly report· Mar 31, 2026(SEC EDGAR)
  9. 8-K
    Current report· May 6, 2026(SEC EDGAR)
    • 5.07Shareholder vote results
  10. 8-K
    Current report· Apr 30, 2026(SEC EDGAR)
    • 2.02Results of operations
    • 9.01Financial statements and exhibits
All filings on SEC EDGAR

Frequently asked questions

What does STRYKER CORP do?

The SEC classifies STRYKER CORP under Standard Industrial Classification (SIC) code 3841, "Surgical & Medical Instruments & Apparatus". It is headquartered in Portage, MI. It is incorporated in MI. In fiscal 2025 it reported revenue of $25.12B and net income of $3.25B in its annual 10-K report.

What was STRYKER CORP's revenue in 2025?

STRYKER CORP reported revenue of $25.12B for fiscal 2025, which ended Dec 31, 2025, up 11.2% from $22.6B in fiscal 2024, according to its annual 10-K report filed with the SEC on Feb 11, 2026.

What was STRYKER CORP's net income in 2025?

STRYKER CORP reported net income of $3.25B for fiscal 2025, a net margin of 12.9% of revenue.

Where is STRYKER CORP listed?

According to the SEC, STRYKER CORP's ticker SYK is listed on NYSE.

When does STRYKER CORP's fiscal year end?

According to the SEC, STRYKER CORP's fiscal year ends on December 31; its latest reported fiscal year (2025) ended Dec 31, 2025.

Source: SEC EDGAR · Last updated:

Ver en español

Not investment advice: This page shows financial data that companies reported to the US Securities and Exchange Commission, for information only. It is not investment advice or a recommendation to buy or sell any security, and it shows no stock prices. Data may be incomplete, restated or out of date — check the original filings on SEC EDGAR before making decisions.